ArticleFrontiers in pediatrics2025
Bedside counseling on complementary medicine as a new model in pediatric cancer care-protocol of the SiKOM multicenter prospective cohort study.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: An open dialogue between parents of children with cancer and medical staff about the benefits, risks, and interactions of complementary medicine used during cancer treatment is essential to enhance treatment safety and efficacy. However, both parents and medical staff often lack sufficient knowledge and willingness to engage in such discussions. To address this, bedside counseling for patients and families is proposed, provided directly by an external team comprising experienced specialists in complementary and conventional medicine. This approach aims to facilitate communication, improve understanding, and mitigate risks associated with complementary medicine during pediatric cancer care. Methods: This study will be conducted in five pediatric cancer centers in Germany. Physicians specializing in complementary medicine and pediatric oncology will provide bedside counseling to patients, parents, and local medical staff. Feasibility and change measures will be evaluated by comparing cohorts of parents who received complementary medicine counseling with those who did not, as well as medical staff before and after training sessions. Semi-structured interviews with parents and medical staff will further explore barriers to complementary medicine counseling and identify strategies to enhance its implementation. Quantitative data will be analyzed to assess the feasibility of the intervention, while qualitative data will provide in-depth insights into the perspectives and experiences of stakeholders. Results: The results will highlight predictors for effective, use-oriented counseling tailored to different target groups. This prototype support care model will serve as a framework for implementing complementary medicine counseling both within and beyond inpatient pediatric oncology settings. By integrating these findings, we aim to develop a replicable approach to complementary medicine counseling that addresses the unique needs of pediatric cancer patients, their families, and medical professionals. Discussion: Previous initiatives have primarily focused on training individual physicians within each center to address complementary medicine. In contrast, this novel strategy emphasizes direct bedside counseling for pediatric patients and families while providing ongoing support to local staff. This approach seeks to enhance treatment safety by reducing unintended interactions between complementary medicine and conventional cancer therapies, ultimately improving care quality and patient outcomes. Trial Registration: German Clinical Trials Register (DRKS), ID: DRKS00030478. Registered 22 December 2022 https://www.drks.de/DRKS00030478.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.